glp-1 receptor agonists effectiveness comparison Drug in Diabetes and Obesity Treatment GLP-1 Receptor Agonists for Weight
Description
More recent agents include dual agonists such as tirzepatide, which activates both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors and produces even greater weight loss
[DOI] [PubMed] [Google Scholar] 853.Foltynie T., Aviles-Olmos I
As patents evolve and global pharmaceutical markets shift, conversations about lower-cost GLP-1 therapies are gaining momentum
Side effects are numerous include xerostomia, palpitations, dysgeusia and hypertension [156]
[DOI] [PubMed] [Google Scholar] 199.Weinstock RS, Guerci B, Umpierrez G, Nauck MA, Skrivanek Z, Milicevic Z
